Retra Life Sciences Private Limited, a active private limited company, was established on 25 September 2019 in Bengaluru, Karnataka, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24239KA2019PTC128286. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.40 Cr and a paid-up capital of ₹1.40 Cr.
It upholds a compliant status. Its leadership includes Shobha Venkatesh (Director), Periganji Radhakrishna Ishwarya (Additional Director), Ganiga Srinivasaiah Manjunatha (Additional Director). Past directors included Mamatha Channabasana Patil. It holds ₹5.00 M open charges and ₹1.70 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No.19 & 20, 3Rd Floor, 1St Main Road, Above Karnataka Bank, Byatarayanapura, M, Ysore Road, Bengaluru, Karnataka, 560026.
U24239KA2019PTC128286
128286
25 September 2019
₹1.40 Cr
₹1.40 Cr
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Retra Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shobha Venkatesh | Director | 25 Sep 2019 | Current |
| Periganji Radhakrishna Ishwarya | Additional Director | 10 Nov 2022 | Current |
| Ganiga Srinivasaiah Manjunatha | Additional Director | 10 Nov 2022 | Current |
| Pinjiwakkam Nandakumar Subramanyam | Director | 25 Sep 2019 | Current |
| Mamatha Channabasana Patil | Director | 31 Mar 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Retra Life Sciences Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 12.13% decrease. The company also saw a substantial improvement in profitability, with a 77.52% increase in profit. The company's net worth Soared by an impressive increase of 15.6%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Retra Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹5,000,000.00
₹17,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Nov 2023 | Axis Bank Limited | ₹5.00 M | Open |
| 17 Aug 2021 | Others | ₹1.70 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Retra Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Retra Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Retra Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Retra Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Retra Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was documented.
The activity A charge with Axis Bank Limited amounted to Rs. 0.50 Cr with Charge ID 100811039 was registered on 06 Nov 2023. was completed.
A charge registered on 17 Aug 2021 via Charge ID 100479586 with Others was fully satisfied on 12 Apr 2023. was recorded as a recent event.
The activity Periganji Radhakrishna Ishwarya was appointed as a Additional Director was appointed as a Additional Director on 10 Nov 2022 & has been associated with this company since 3 years 1 month . was completed.
The activity Ganiga Srinivasaiah Manjunatha was appointed as a Additional Director was appointed as a Additional Director on 10 Nov 2022 & has been associated with this company since 3 years 1 month . was completed.
The CIN of Retra Life Sciences Private Limited is U24239KA2019PTC128286.
Retra Life Sciences Private Limited is headquartered at No.19 & 20, 3Rd Floor, 1St Main Road, Above Karnataka Bank, Byatarayanapura, M, Ysore Road, Bengaluru, Karnataka, 560026.
Retra Life Sciences Private Limited was incorporated on 25 September 2019.
The current directors of Retra Life Sciences Private Limited are
The primary industry of Retra Life Sciences Private Limited is Trade.
Retra Life Sciences Private Limited is unlisted.
The authorized capital of Retra Life Sciences Private Limited is ₹1.40 Cr, and the paid-up capital is ₹1.40 Cr.
The compliance status of Retra Life Sciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX